Cargando…
The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
SIMPLE SUMMARY: Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer (BC) in which higher levels of stromal tumour-infiltrating lymphocytes (sTIL) before neo-adjuvant chemotherapy (NACT) are associated with a better outcome. The role of sTIL in patients with residual disea...
Autores principales: | Van Berckelaer, Christophe, Vermeiren, Iris, Vercauteren, Leonie, Rypens, Charlotte, Oner, Gizem, Trinh, Xuan Bich, Tjalma, Wiebren A. A., Broeckx, Glenn, Charafe-Jauffret, Emmanuelle, Van Laere, Steven, Bertucci, François, Colpaert, Cecile, van Dam, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471511/ https://www.ncbi.nlm.nih.gov/pubmed/34572883 http://dx.doi.org/10.3390/cancers13184656 |
Ejemplares similares
-
The immune microenvironment characterisation and dynamics in hormone receptor–positive breast cancer before and after neoadjuvant endocrine therapy
por: Oner, Gizem, et al.
Publicado: (2023) -
A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer
por: Van Berckelaer, C., et al.
Publicado: (2020) -
Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression
por: Van Berckelaer, C., et al.
Publicado: (2019) -
In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment
por: van Dam, Peter A., et al.
Publicado: (2015) -
Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis
por: Najim, Omar, et al.
Publicado: (2023)